| Titolo |
Pubblicato in |
Anno |
| Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment |
ESMO OPEN |
2020 |
| Identification of aneuploid circulating tumor cells in soft-tissue sarcoma patients: a pilot study |
ONCOLOGY |
2020 |
| Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: a review |
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2020 |
| Is There Still a Role for Endocrine Therapy Alone in HR+/HER2-Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies |
BREAST CARE |
2020 |
| Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis |
ESMO OPEN |
2020 |
| The emerging role of PARP inhibitors in prostate cancer |
EXPERT REVIEW OF ANTICANCER THERAPY |
2020 |
| Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab |
GASTRIC CANCER |
2020 |
| Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial |
THE LANCET ONCOLOGY |
2020 |
| Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study |
JCO PRECISION ONCOLOGY |
2020 |
| Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report |
THE BREAST JOURNAL |
2020 |
| Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis (Targeted Oncology, (2020), 15, 4, (495-501), 10.1007/s11523-020-00732-y) |
TARGETED ONCOLOGY |
2020 |
| Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report |
THE BREAST JOURNAL |
2020 |
| Regression of papillary thyroid cancer during nivolumab for renal cell cancer |
EUROPEAN THYROID JOURNAL |
2020 |
| Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report |
PRECISION CANCER MEDICINE |
2020 |
| Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience |
JOURNAL OF CELLULAR PHYSIOLOGY |
2019 |
| No evidence of association between psychological distress and pain relief in patients with bone metastases from castration‐resistant prostate cancer treated with 223Radium |
EUROPEAN JOURNAL OF CANCER CARE |
2019 |
| Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting |
INTERNATIONAL JOURNAL OF CANCER |
2019 |
| Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab. a real-life multicentre study |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2019 |
| A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2019 |
| Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice |
JOURNAL OF TRANSLATIONAL MEDICINE |
2019 |
